Critical Response to Article "Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer"

被引：0
|
作者：
Dany, Frans [1 ]
Nikmah, Uly Alfi [1 ]
Lienggonegoro, Lisa Andriani [1 ]
机构：
[1] Natl Res & Innovat Agcy BRIN, Ctr Biomed Res, Hlth Res Org, Genom Bldg,Jl Raya Bogor 490, Cibinong 16911, West Java, Indonesia
来源：
DRUG DESIGN DEVELOPMENT AND THERAPY | 2023年 / 17卷
关键词：
D O I：
10.2147/DDDT.S417549
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2455 / 2456
页数：2
相关论文
共 50 条
  • [31] Exploration of the mechanism of luteolin against colorectal cancer based on network pharmacology and experimental validation
    Zhang, Wenjun
    Zhang, Fujie
    ASIAN JOURNAL OF SURGERY, 2025, 48 (02) : 1597 - 1598
  • [32] Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer
    Xu, Xingchao
    Zhang, Jimei
    Zhang, Zhenhua
    Wang, Meng
    Liu, Yaping
    Li, Xiangqi
    BIOENGINEERED, 2020, 11 (01) : 1170 - 1188
  • [33] Spherical nucleic acids induce an antitumor immune response against triple-negative breast cancer
    Cole, Lisa E.
    Horiuchi, Dai
    Mirkin, Chad A.
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Identifying the mechanism of polysaccharopeptide against breast cancer based on network pharmacology and experimental verification
    Xu, Cuixiang
    Sun, Lijun
    Wang, Huxia
    Sun, Jingying
    Feng, Yangmeng
    Wang, Xingguang
    Song, Zhangjun
    BMC CANCER, 2024, 24 (01)
  • [35] Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology
    Li, Ming
    Zhao, Yuan
    Li, Huimin
    Kang, Shiyao
    Deng, Xuming
    Sheng, Miaomiao
    AGING-US, 2024, 16 (03): : 2848 - 2865
  • [36] Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification
    Deng, Zhicheng
    Chen, Guanghui
    Shi, Yonghui
    Lin, Ying
    Ou, Jiebin
    Zhu, Hua
    Wu, Junyan
    Li, Guocheng
    Lv, Li
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
    Ensenyat-Mendez, Miquel
    Orozco, Javier I. J.
    Llinas-Arias, Pere
    Iniguez-Munoz, Sandra
    Baker, Jennifer L.
    Salomon, Matthew P.
    Marti, Merce
    DiNome, Maggie L.
    Cortes, Javier
    Marzese, Diego M.
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [38] Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments
    Chen, Lulu
    Yang, Aishen
    Li, Yangan
    Liu, Xin
    Jiang, Wei
    Hu, Kehui
    MEDICINE, 2023, 102 (37) : E34835
  • [39] Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
    Miquel Ensenyat-Mendez
    Javier I. J. Orozco
    Pere Llinàs-Arias
    Sandra Íñiguez-Muñoz
    Jennifer L. Baker
    Matthew P. Salomon
    Mercè Martí
    Maggie L. DiNome
    Javier Cortés
    Diego M. Marzese
    Communications Medicine, 3
  • [40] Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines
    Sevda Jafari
    Sheida Dabiri
    Elnaz Mehdizadeh Aghdam
    Ezzatollah Fathi
    Nazli Saeedi
    Soheila Montazersaheb
    Raheleh Farahzadi
    Clinical and Translational Oncology, 2023, 25 : 2559 - 2568
12345